Analyst Reco. Merck & Co., Inc. Swiss Exchange

Equities

MRK

US58933Y1055

Market Closed - Swiss Exchange Other stock markets 10:06:38 05/12/2022 pm IST			5-day change	1st Jan Change
400 ^CHF	+388.82%		-.--%	-.--%

28/06	Merck: positive opinion for Winrevair in Europe	CF
28/06	Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension	DJ

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating	05/06	MT
ANALYST RECOMMENDATIONS : Boeing, Dell, Merck, RyanAir...	27/05
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142	01/05	MT
Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	26/04	MT
Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	26/04	MT
Guggenheim Adjusts Price Target on Merck to $146 From $144	26/04	MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	26/04	MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135	26/04	MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140	26/04	MT
Goldman Sachs Raises Price Target on Merck & Company to $144 From $139	26/04	MT
Leerink Partners Raises Price Target on Merck & Company to $136 From $132	26/04	MT
Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating	26/04	MT
Jefferies Adjusts Merck & Company Price Target to $150 From $145	26/04	MT
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating	25/04	MT
BMO Capital Adjusts Price Target on Merck & Company to $148 From $132	19/04	MT
Leerink Partners Raises Merck's Price Target to $134 From $129	19/04	MT
Zacks Adjusts Price Target on Merck & Company to $132 From $128	15/04	MT
Berenberg Raises Price Target on Merck & Company to $143 From $140, Maintains Buy Rating	08/04	MT
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating	27/03	MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating	27/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc. Swiss Exchange

Equities

MRK

US58933Y1055

Analyst Reco.

Filters